# Guanfacine - Alpha-2 adrenergic agonist
# Approved in US, EU, Japan; not available in China

id: "guanfacine"

brandNames:
  US: ["Intuniv", "Tenex"]
  CN: []
  EU: ["Intuniv"]
  JP: ["インチュニブ (Intuniv)"]
  UK: ["Intuniv"]
  AU: ["Intuniv"]
  CA: ["Intuniv"]

genericName: "guanfacine hydrochloride"

manufacturers:
  - name: "Takeda (formerly Shire)"
    region: "US"
    product: "Intuniv"
  - name: "Shionogi"
    region: "JP"
    product: "インチュニブ"

# Classification
drugClass: "non-stimulant"
category: "alpha-2 adrenergic agonist"
controlledSubstance: false
schedule:
  US: "Not scheduled"
  CN: "Not approved"
  EU: "Not scheduled"
  JP: "Not scheduled"
  UK: "Not scheduled"

# Mechanism
activeIngredient: "guanfacine hydrochloride"
mechanismOfAction: "Selective alpha-2A adrenergic receptor agonist. Stimulates receptors in the prefrontal cortex, strengthening working memory, reducing distractibility, and improving impulse control. Also has calming effect by reducing sympathetic outflow."
neurotransmittersAffected:
  - norepinephrine

# Dosage & Forms
forms:
  - type: "tablet"
    releaseType: "extended"
    brandName: "Intuniv"
    strengths: ["1mg", "2mg", "3mg", "4mg"]
    durationHours: 24
    notes: "Extended-release for ADHD; must swallow whole"

  - type: "tablet"
    releaseType: "immediate"
    brandName: "Tenex"
    strengths: ["1mg", "2mg"]
    durationHours: 8-12
    notes: "Immediate-release; originally for hypertension; not FDA-approved for ADHD"

# Efficacy
onsetMinutes: null  # Gradual effect over weeks
peakEffectHours: 5
durationHours: 24

# Side Effects
sideEffects:
  common:
    - name: "somnolence/fatigue"
      frequency: "30-40%"
    - name: "headache"
      frequency: "20-25%"
    - name: "dizziness"
      frequency: "10-15%"
    - name: "decreased appetite"
      frequency: "10-15%"
    - name: "abdominal pain"
      frequency: "10%"
    - name: "dry mouth"
      frequency: "10%"
    - name: "nausea"
      frequency: "5-10%"
    - name: "constipation"
      frequency: "5%"

  uncommon:
    - name: "hypotension"
      frequency: "5-10%"
    - name: "bradycardia"
      frequency: "5%"
    - name: "irritability"
      frequency: "5%"
    - name: "insomnia"
      frequency: "5%"

  serious:
    - name: "hypotension"
      notes: "Can cause significant drops in blood pressure"
    - name: "bradycardia"
      notes: "May slow heart rate"
    - name: "syncope"
      notes: "Fainting due to blood pressure drop"
    - name: "rebound hypertension"
      notes: "If stopped abruptly; must taper"
    - name: "sedation"
      notes: "Can be severe, especially initially"

# Safety
contraindications:
  - "Hypersensitivity to guanfacine"
  - "Severe bradycardia"
  - "Heart block"

drugInteractions:
  - drug: "CYP3A4 inhibitors (ketoconazole)"
    severity: "moderate"
    effect: "Increased guanfacine levels"
  - drug: "CYP3A4 inducers (rifampin)"
    severity: "moderate"
    effect: "Decreased guanfacine levels"
  - drug: "Antihypertensives"
    severity: "moderate"
    effect: "Additive hypotensive effect"
  - drug: "CNS depressants"
    severity: "moderate"
    effect: "Enhanced sedation"
  - drug: "Valproic acid"
    severity: "moderate"
    effect: "Increased guanfacine exposure"

blackBoxWarnings: []

pregnancyCategory: "B"
foodInteractions: "Avoid high-fat meals (increases absorption); avoid grapefruit juice"

# Practical Information
typicalDosing:
  children:
    startingDose: "1mg once daily"
    maxDose: "4mg/day (children 6-12) or 7mg/day (adolescents)"
    notes: "Increase by 1mg weekly; take at same time daily (morning or evening)"
  adults:
    startingDose: "1mg once daily"
    maxDose: "4mg/day (off-label for adults)"
    notes: "Not FDA-approved for adult ADHD but commonly used"

costEstimate:
  US:
    brand: "$300-400/month"
    generic: "$50-100/month"
  CN:
    brand: "Not available"
    generic: "Not available"

storageRequirements: "Room temperature (25°C), protect from light and moisture"

# Approval & Availability
approvals:
  - region: "US"
    agency: "FDA"
    year: 2009
    approvedAges: "6-17 years"
    indications:
      - "ADHD"
    available: true
    notes: "Approved for children/adolescents; off-label for adults; can be used alone or with stimulants"

  - region: "CN"
    agency: "NMPA"
    year: null
    approvedAges: ""
    indications: []
    available: false
    notes: "Not approved in China"

  - region: "EU"
    agency: "EMA"
    year: 2015
    approvedAges: "6-17 years"
    indications:
      - "ADHD"
    available: true
    notes: "First ADHD medication approved through EMA centralized procedure"

  - region: "JP"
    agency: "PMDA"
    year: 2017
    approvedAges: "6-17 years"
    indications:
      - "ADHD"
    available: true
    notes: "No registration requirement (unlike stimulants)"

  - region: "UK"
    agency: "MHRA"
    year: 2016
    approvedAges: "6-17 years"
    indications:
      - "ADHD"
    available: true
    notes: ""

  - region: "AU"
    agency: "TGA"
    year: 2013
    approvedAges: "6-17 years"
    indications:
      - "ADHD"
    available: true
    notes: ""

  - region: "CA"
    agency: "Health Canada"
    year: 2013
    approvedAges: "6-17 years"
    indications:
      - "ADHD"
    available: true
    notes: ""

# Special Considerations
specialConsiderations:
  cardiacRisk: "Can lower blood pressure and heart rate; use caution with cardiac conditions"
  abuseRisk: "No abuse potential; not a controlled substance"
  withdrawalNotes: "MUST TAPER - stopping abruptly can cause rebound hypertension"
  monitoringRequired: "Blood pressure, heart rate; especially when starting or changing dose"

# Metadata
lastUpdated: 2025-12-02
sources:
  - "https://www.goodrx.com/conditions/adhd/non-stimulant-adhd-meds"
  - "https://www.ema.europa.eu/en/news/ema-recommends-approval-treatment-attention-deficit-hyperactivity-disorder"
  - "https://h-navi.jp/column/article/35028853"

notes: "Good option for hyperactivity/impulsivity symptoms or when stimulants cause anxiety. Particularly helpful for emotional dysregulation. Can be combined with stimulants. Must taper when discontinuing. Not approved for adult ADHD but commonly used off-label."
